| 000 | 01756 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515223222.0 | ||
| 264 | 0 | _c20100812 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1940-1574 | ||
| 024 | 7 |
_a10.1177/0003319710366431 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRizzo, Manfredi | |
| 245 | 0 | 0 |
_aEffects of rosiglitazone on fasting and postprandial low- and high-density lipoproteins size and subclasses in type 2 diabetes. _h[electronic resource] |
| 260 |
_bAngiology _cAug 2010 |
||
| 300 |
_a584-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aFasting |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPostprandial Period _xdrug effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aThiazolidinediones _xadministration & dosage |
| 700 | 1 | _aVekic, Jelena | |
| 700 | 1 | _aKoulouris, Spyridon | |
| 700 | 1 | _aZeljkovic, Aleksandra | |
| 700 | 1 | _aJelic-Ivanovic, Zorana | |
| 700 | 1 | _aSpasojevic-Kalimanovska, Vesna | |
| 700 | 1 | _aRini, Giovam Battista | |
| 700 | 1 | _aSakellariou, Dimitrios | |
| 700 | 1 | _aPastromas, Socrates | |
| 700 | 1 | _aMikhailidis, Dimitri P | |
| 700 | 1 | _aManolis, Antonis S | |
| 773 | 0 |
_tAngiology _gvol. 61 _gno. 6 _gp. 584-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0003319710366431 _zAvailable from publisher's website |
| 999 |
_c19817637 _d19817637 |
||